Today, a Director at Becton Dickinson (BDX), Catherine Burzik, sold shares of BDX for $10.04K.
In addition to Catherine Burzik, one other BDX executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
BDX’s market cap is $63.12B and the company has a P/E ratio of 69.44. Currently, Becton Dickinson has an average volume of 341.3K.
Based on 7 analyst ratings, the analyst consensus is Strong Buy with an average price target of $268.00, reflecting a 14.5% upside.
In the last 30 days, insiders have sold $3.78M worth of BDX shares and purchased $82.57K worth of BDX shares. The insider sentiment on Becton Dickinson has been negative according to 70 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
